Enhanced Valves Interventions and Safe AI Generated End Results

Recruiting Observational Study
Heart Valve Disease TAVI M-TEER TTVI TMVI T-TEER Mitraclip TriClip
No Placebo Group Every participant receives an active treatment — no one gets a placebo. No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Study type
Observational
Participants needed
21,000 (estimated)
Sponsor
Montreal Heart Institute · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial

This non-interventional study aims to use artificial intelligence to improve the prediction of transcatheter heart valve interventions and optimize patient outcomes. It is based on the analysis of retrospective data from various specialized centers worldwide.

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: Patients who have reached the age of legal majority under local laws. * For TAVI group: All patients who have had TAVI with a third generation transcatheter heart valve (THV), with an available pre-procedural optimal quality CT scan as defined by an ECG- gating CT with: 1. f…
Contacts

Thomas Modine, MD, PhD

+33(0)5 25 377541

thomasmodine@gmail.com

CONTACT

Walid Ben Ali, MD, PhD

+1 5145611037

dr.walidbenali@gmail.com

CONTACT